• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov11
Ironwood Pharma released FY2025 Q3 earnings on November 10 (EST), actual revenue USD 122.06 M (forecast USD 75.7 M), actual EPS USD 0.2293 (forecast USD 0.1166)
04:00
Ironwood Pharma released FY2025 9 Months Earnings on November 10, 2025 (EST) with actual revenue of USD 248.44 M and EPS of USD 0.1344
04:00
Nov6
Linzess approved by FDA for pediatric IBS-C treatment
11:41
Aug8
Ironwood Pharma released FY2025 Q2 earnings on August 7 (EST), actual revenue USD 85.24 M (forecast USD 62.02 M), actual EPS USD 0.14 (forecast USD 0.0233)
03:00
Ironwood Pharma released FY2025 Semi-Annual earnings on August 7 (EST), actual revenue USD 126.38 M, actual EPS USD -0.09
03:00
May20
Ironwood Pharmaceuticals COO Disposes of Common Stock
20:11

Schedules & Filings

Schedules
Filings
Nov10
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 122.06 M, Net Income 40.08 M, EPS 0.2293

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 85.24 M, Net Income 23.6 M, EPS 0.1373

May7
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 41.14 M, Net Income -37.39 M, EPS -0.2322

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SEVNR
0.0280
+218.18%
+0.019
SMX
141.000
+141.07%
+82.510
PLRZ
14.500
+104.51%
+7.410
PMI
3.690
+82.67%
+1.670
SNCR
8.710
+64.34%
+3.410
PMCB
1.210
+54.22%
+0.425
QCLS
6.920
+48.18%
+2.250
ANPA
21.860
+40.67%
+6.320
HYNE
14.000
+40.00%
+4.000
ASTX
46.070
+36.50%
+12.320
View More